Michelle Werner
Directeur/Bestuurslid bij OMEGA THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Michelle Werner
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Pennsylvania
305
| College/University | Other Consumer Services | 305 |
| Public Company | Pharmaceuticals: Major | 181 | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
173
| Private Company | Investment Managers | 173 |
London Business School
140
| College/University | Other Consumer Services | 140 |
| Public Company | Pharmaceuticals: Major | 70 | |
| Public Company | Biotechnology | 18 | |
Alltrna
 Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.
3
| Holding Company | Biotechnology | 3 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michelle Werner via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Founder Director/Board Member Director of Finance/CFO Director/Board Member | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Director/Board Member | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Founder Director/Board Member Founder Founder | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member Chairman | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| MEAD JOHNSON NUTRITION CO | Food: Meat/Fish/Dairy | Chairman Director/Board Member Director/Board Member | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Director/Board Member Chief Executive Officer | |
| Flagship Labs 89, Inc. | Biotechnology | Founder Chief Executive Officer Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
CiBO Technologies, Inc.
 CiBO Technologies, Inc. Packaged SoftwareTechnology Services CiBO Technologies, Inc. is a science-driven software company which engage sin the modelling and simulation of agricultural ecosystems. The firm offers CIBO and CIBO Plus software products. The company was founded by Ignacio Bemposta Martinez and Bruno Basso in 2015 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member Director/Board Member Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Chairman | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Michigan State University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree | |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Founder President | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO Director/Board Member | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Private Equity Investor Private Equity Investor | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Founder | |
| Vanderbilt University | College/University | Masters Business Admin Doctorate Degree | |
| The Boston Consulting Group | Consultant / Advisor Consultant / Advisor | ||
| Temple University (Pennsylvania) | College/University | Undergraduate Degree Graduate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Sales & Marketing | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member Chairman | |
| BG MEDICINE, INC. | Medical Specialties | Founder Director of Finance/CFO | |
| McDonough School of Business | College/University | Graduate Degree Masters Business Admin | |
| London School of Economics & Political Science | College/University | Graduate Degree Undergraduate Degree | |
| Stonehill College, Inc. | College/University | Director/Board Member Undergraduate Degree | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Human Resources Officer | |
| Purdue University | College/University | Masters Business Admin Undergraduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Verenigd Koninkrijk | 3 |
| Mexico | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 18 |
| Commercial Services | 6 |
| Finance | 3 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 438 |
| Corporate Officer/Principal | 160 |
| Independent Dir/Board Member | 117 |
| Chairman | 105 |
| Undergraduate Degree | 81 |
Sterkste connecties
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Margo Georgiadis | 34 |
| Ed Kania | 31 |
| Michael Rosenblatt | 31 |
| Sherilyn McCoy | 27 |
| John Mendlein | 27 |
| Theo Melas-Kyriazi | 26 |
| Philip Broadley | 24 |
| James Cornelius | 23 |
| Leif Valdemar Johansson | 21 |
| Thomas Lynch | 20 |
| Brian Daniels | 20 |
| Mary Szela | 19 |
| Luke Beshar | 19 |
| Ian Michael Laing | 19 |
- Beurs
- Insiders
- Michelle Werner
- Bedrijfsconnecties
